Thermo Fisher Scientific TMO Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $3.28B-66.8% | $9.88B+391% | $2.01B-56.3% | $4.6B+10.3% | $4.17B+3.3% | ||
| $22.32B-22.3% | $28.71B+28.8% | $22.3B-9.3% | $24.58B+5.2% | $23.38B+5.6% | ||
| $10.66B+0.9% | $10.57B+3.8% | $10.18B+5.6% | $9.64B+3.3% | $9.33B+0.3% | ||
| $55.19B+11.8% | $49.36B+0.2% | $49.29B+4.3% | $47.25B+1.6% | $46.49B+1.4% | ||
| $113.28B+2.7% | $110.34B+7.1% | $103.02B+1.8% | $101.23B+2.2% | $99.04B+1.8% | ||
| $2.93B+8.0% | $2.71B-5.0% | $2.85B+1.7% | $2.81B-2.1% | $2.87B+0.5% | ||
| $14.62B-3.7% | $15.19B+2.0% | $14.89B+17.1% | $12.72B-3.5% | $13.17B-1.2% | ||
| $42.95B+9.6% | $39.17B+10.4% | $35.48B+1.3% | $35.03B+3.1% | $33.99B+9.4% | ||
| $767M+46.9% | $522M— | —— | —— | —— | ||
| $60.63B+2.5% | $59.16B+3.1% | $57.35B+2.6% | $55.9B+2.7% | $54.45B+2.5% | ||
| $51.93B-2.8% | $53.41B+4.7% | $51.02B+1.0% | $50.51B+2.3% | $49.39B-0.4% | ||
| $113.28B+2.7% | $110.34B+7.1% | $103.02B+1.8% | $101.23B+2.2% | $99.04B+1.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Thermo Fisher Scientific's total assets?
- Thermo Fisher Scientific (TMO) holds $113.28B in total assets, up 14.4% year over year.
- How much debt does Thermo Fisher Scientific have?
- Thermo Fisher Scientific carries $43.2B in total debt against $51.9B of shareholders' equity, a debt-to-equity ratio of 0.83.
- How much cash does Thermo Fisher Scientific have?
- Thermo Fisher Scientific holds $3.3B in cash and equivalents.
- Can Thermo Fisher Scientific cover its short-term obligations?
- Its current ratio is 1.53 — current assets exceed current liabilities.
- Where does Thermo Fisher Scientific's balance sheet data come from?
- Every line is extracted from Thermo Fisher Scientific's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
